Autonomix Medical, Inc. vs Johnson & Johnson
AMIX vs JNJ — side-by-side comparison from reported financials. AMIX leads 0, JNJ leads 5 of 5 comparable metrics.
Autonomix Medical, Inc.
AMIX · Healthcare
$2.87-2.05%Mixed
Johnson & Johnson
JNJ · Healthcare
$255.00+0.68%Solid
| Metric | AMIX | JNJ |
|---|---|---|
| Price | $2.87 | $255.00 |
| Market cap | $10.0M | $615B |
| Revenue (TTM) | — | $97.9B |
| Revenue growth | — | +5.6% |
| Net margin | — | 21.5% |
| Free cash flow | -$13.2M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | -87.7% | +32.7% |
| P/E | — | 38.8 |
| P/E vs own history (cheap-side %) | — | 18% |
| Dividend yield | — | 2.02% |
| Return on equity | -268% | 26% |
| Altman Z-score | -24.77 | 5.37 |
| CV checks passed | 1 of 8 | 11 of 8 |
| Employees | 11 | 140,800 |
Full résumé-style profiles: AMIX CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.